| J3380 | Injection, vedolizumab, intravenous, 1 mg | 9,510 | $20 | $161.7K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 1,940 | $30 | $50.4K |
| 45385 | The provider examines the colon and rectum using a colonoscope, a long, thin flexible tubular instrument with a light source and camera. He removes one or more tumors, polyps, or other lesions with a… | 220 | $200 | $44.6K |
| 45380 | The provider examines the rectum and colon using a flexible colonoscope, a tubular instrument with a light source and camera, to look for the cause of a patient's symptoms, which may include… | 240 | $90 | $22.6K |
| J0897 | Injection, denosumab, 1 mg | 1,140 | $20 | $20.5K |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | 100 | $180 | $17.9K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 90 | $100 | $8.5K |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 50 | $170 | $8.3K |
| 43239 | The provider inserts a flexible endoscope through the mouth and down into the esophagus, stomach, and duodenum where he removes one or more tissue biopsy specimens for diagnostic analysis. | 80 | $70 | $5.7K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 80 | $60 | $4.9K |